Skip to content
‹ Back to IndustriesSciences

The Best of CES 2019: Our Favorite Technologies

MarketScale highlighted standout technologies at CES 2019, a significant event showcasing innovation across various industries. Key exhibitors included DJI Enterprise, Segway, Samsung, and Omron, each presenting groundbreaking products that attracted attention from attendees.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Bronson Anderson · ·
Share
The Best of CES 2019: Our Favorite Technologies

Key takeaways

01

DJI's Osmo Pocket offers handheld camera stabilization for flawless footage on the move.

02

Omron's AI-enabled table tennis tutor, Forpheus, demonstrated impressive machine learning capabilities.

03

Segway showcased its Ninebot lineup, including the AI-enhanced Loomo mobile assistant.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

In a sea of technological innovation, it can be hard to stick out. At CES 2019 in Las Vegas, MarketScale was in search of the companies and products that are on the verge of transforming several industries. These displays in particular caught our eye:

DJI Enterprise

DJI, a leader in the drone industry, has been winning at CES with a product that is meant for the ground. It’s Osmo Pocket handheld camera with stabilized gimbal allows users to capture flawless footage on the move.

Malta the Psycho VR

Many industries are still only learning how to utilize virtual reality to improve business. At CES 2019, Malta the Psycho is showcasing everything VR can achieve. From a roller coaster simulation to immersive gaming, this technology is poised to continue its breakout.

Segway

Segway kept CES on the move by showcasing its Ninebot lineup. Visitors to its exhibit were able to check out everything from the Segway KickScooter to the GoKart Kit as well as Loomo, a new mobile AI sidekick. Loomo uses advanced computer vision which allows the mobile assistant to follow its user around if he or she chooses to get off the device and walk.

Samsung Galaxy

Samsung did not publicly debut its much-anticipated foldable cell phone on the main stage at CES, but the company still had a tantalizing exhibition. Everything from a DJ booth to VR racing controlled by Galaxy phones gripped attendees’ attention and made for an interactive experience with Samsung’s newest products.

Omron

Automation is being implemented in almost every industry, and now ping pong can be added to the list. Omron’s AI-enabled table tennis tutor was one of the most impressive pieces of technology on the show floor. ‘Forpheus’ has been turning attendees’ heads with its natural reflexes and elite use of machine learning.

For the latest news, videos, and podcasts in the Software & Electronics Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @TechMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

BA
Bronson Anderson
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Antibody developability checks are moving into discovery instead of waiting for development

Antibody developability checks are moving into discovery instead of waiting for development

Maria Gonzalez-Pajuelo of FairJourney Bio says the order in antibody discovery is changing: developability has become a much more important consideration during discovery, rather than an issue left until later-stage development. The goal, she says, is that what comes out of discovery is something CMC can take forward easily.

  • 01Discovery-stage developability screens can rank many antibodies tested once or twice and may reduce surprises later in development, while development still focuses on several lots of a single antibody and answers different questions.

Oct 1, 2026

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

ISPE’s 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC describing how the tracks connect—and why AI is treated as a cross-cutting topic rather than a standalone track. Deloitte’s December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE’s 2026 Annual Meeting has no dedicated AI track; executive chair Jose Caraballo expects AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte’s December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own outlook but only 41% optimistic about the global economy, a mood the story says the ISPE chairs are programming for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site designs preclinical tumor models to match specific therapies and delivery routes, rather than forcing treatments into standard study designs. It combines custom surgical procedures, cell line-derived xenografts, patient-derived xenografts (including post-treatment models), and biomarker capabilities to generate translational data that can help sponsors decide whether to advance a program.

  • 01Orthotopic brain tumor implantation using tagged models lets researchers track tumor growth in the original organ, aligning the model and delivery route with how therapies are intended to be tested.
  • 02Patient-derived xenografts developed from tumors after prior treatment may better reflect progressed disease, helping teams study therapies aimed at patients whose cancer has advanced after earlier treatment.
  • 03Combining biomarker analysis of preclinical model samples with clinical sample testing at one site could make it easier to connect what is measured in animals with what is later measured in patients.

Sep 30, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

BA
Bronson Anderson

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512